Figure 2A shows that the positive rates of HLA‐G and PD‐L1 expression were approximately 53.5% and 51% in NSCLC tumor samples (n = 24), respectively, and 51.9% and 31.9% in TNBC (n = 30), respectively (Figure 2B). The gene discussed is CD274; the disease is neoplasm.